Search results for "benzimidazole"

showing 10 items of 161 documents

CCDC 191616: Experimental Crystal Structure Determination

2003

Related Article: J.R.Galan-Mascaros, K.R.Dunbar|2003|Angew.Chem.,Int.Ed.|42|2289|doi:10.1002/anie.200250152

Space GroupCrystallographycatena-(hexakis(mu~2~-1H-22'-Bibenzimidazole)-diaqua-tetrachloro-penta-cobalt(ii) toluene methanol solvate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Hydrogels for potential colon drug release by thiol-ene conjugate addition of a new inulin derivative.

2008

Inulin was chosen as a starting polymer for biocompatible, pH-sensitive and biodegradable hydrogels. Three INUDVSA-TT hydrogels were obtained by crosslinking inulin derivatives with trimethylolpropane tris(3-mercaptopropionate) under varying conditions. The resulting hydrogels were cell compatible, as demonstrated by MTS and trypan blue exclusion assays acting on Caco-2 cells, and were biodegraded by inulinase and esterase, thus suggesting their use as colonic drug delivery systems. 2-Methoxyestradiol, an anti-cancer drug, was soaked in INUDVSA-TT hydrogels and its in vitro release and apoptotic effect on Caco-2 cells were evaluated.

Succinic AnhydridesPolymers and PlasticsCell SurvivalColonInulinBioengineeringmacromolecular substancesDNA Fragmentationcomplex mixturesBiomaterialschemistry.chemical_compoundDrug Delivery SystemsMaterials ChemistryOrganic chemistryHumansSulfhydryl CompoundsSulfonesHYDROGELS INULIN DRUG TARGETING COLON DELIVERYTrimethylolpropaneParticle SizeEstradioltechnology industry and agricultureInulinHydrogelsCombinatorial chemistry2-MethoxyestradiolMolecular WeightCross-Linking ReagentschemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSelf-healing hydrogelsDrug deliveryBisbenzimidazoleLiberationTrypan blueCaco-2 CellsDrug carrierBiotechnologyConjugateMacromolecular bioscience
researchProduct

Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.

2004

1. A study performed > 10 years ago and case reports published recently suggest that triclabendazole is effective for the treatment of patients with fascioliasis. 2. To confirm the efficacy of a human formulation of triclabendazole, we enrolled 165 patients into the present study and divided the subjects into two groups: (i) those who had fascioliasis, as evidenced by the presence of ova in their stools; and (ii) patients with clinical and laboratory data suggesting fascioliasis. 3. Patients were randomly allocated to receive 10 mg/kg, p.o., triclabendazole for 1, 2 or 3 days (single-, double- and triple-dose groups, respectively). Medical history and physical and laboratory examinations we…

Toxic hepatitisAdultMalemedicine.medical_specialtyCure rateFascioliasisAdolescentPhysiologyChemistry PharmaceuticalGastroenterologylaw.inventionFecesRandomized controlled triallawOral administrationPhysiology (medical)Internal medicineMedicineHumansMedical historyIn patientChildTriclabendazoleAgedPharmacologyAnthelminticsDose-Response Relationship Drugbusiness.industryMiddle AgedSurgeryTriclabendazoleTreatment OutcomeHuman fascioliasisImmunoglobulin GBenzimidazolesFemalemedicine.symptombusinessmedicine.drugClinical and experimental pharmacologyphysiology
researchProduct

CCDC 2095301: Experimental Crystal Structure Determination

2022

Related Article: Javier López-Cabrelles, Eugenia Miguel-Casañ, María Esteve-Rochina, Eduardo Andres-Garcia, Iñigo J. Vitórica-Yrezábal, Joaquín Calbo, Guillermo Mínguez Espallargas|2022|Chemical Science|13|842|doi:10.1039/D1SC04779E

catena-[(2-ethylimidazole)-(2-methylbenzimidazole)-iron(ii) tetrahydrate unknown solvate]Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Benzimidazoles as NMDA Glycine-Site Antagonists: Study on the Structural Requirements in 2-Position of the Ligand

2000

A series of different substituted benzimidazole derivatives has been synthesized and evaluated for the ability to displace [3H]MDL-105,519 to rat cortical membranes. Two benzimidazole-2-carboxylic acids 9 b and 9 c, in this substitution pattern not yet described as glycine antagonists, showed IC50 values of 0.89 microM (9 b) and 38.0 microM (9 c). Replacement of the carboxylate function in 2-position by a sulfonic acid moiety appreciably increased solubility, but decreased the affinity giving evidence for the strong need of the carboxylate group within the ligand. Further structure-activity studies using benzimidazole-2-one derivatives with an acetic acid moiety adjacent to a ring nitrogen …

chemistry.chemical_classificationBenzimidazoleChemistryStereochemistryLigandPharmaceutical ScienceGlycine receptor antagonistSulfonic acidchemistry.chemical_compoundAmideDrug DiscoveryGlycineMoietyCarboxylateArchiv der Pharmazie
researchProduct

ChemInform Abstract: Benzimidazoles as NMDA Glycine-Site Antagonists: Study on the Structural Requirements in 2-Position of the Ligand.

2010

A series of different substituted benzimidazole derivatives has been synthesized and evaluated for the ability to displace [3H]MDL-105,519 to rat cortical membranes. Two benzimidazole-2-carboxylic acids 9 b and 9 c, in this substitution pattern not yet described as glycine antagonists, showed IC50 values of 0.89 microM (9 b) and 38.0 microM (9 c). Replacement of the carboxylate function in 2-position by a sulfonic acid moiety appreciably increased solubility, but decreased the affinity giving evidence for the strong need of the carboxylate group within the ligand. Further structure-activity studies using benzimidazole-2-one derivatives with an acetic acid moiety adjacent to a ring nitrogen …

chemistry.chemical_classificationBenzimidazolechemistry.chemical_compoundChemistryStereochemistryLigandAmideGlycineMoietyGeneral MedicineGlycine receptor antagonistCarboxylateSulfonic acidChemInform
researchProduct

Struktur-Wirkungsbeziehungen bei Histaminanaloga, 14. Mitt. 4-Aminomethyl-benzimidazole und 9-Amino-naphth[1,2-d]imidazole

1977

Es wird die Darstellung der bicyclischen Histaminanaloga 4-Aminomethyl-benzimidazol (3a) und 4-Aminomethyl-4,5,6,7-tetrahydro-benzimidazol (3b) sowie der tricyclischen Analoga 9-Amino-6,7,8,9-tetrahydro-naphth[1,2-d]imidazol (6b) und 9-Amino-4,5,5a,6,7,8,9,9a-octahydro-naphth[1,2-d]imidazol (6c) beschrieben. 4-(Aminomethyl)benzimidazoles and 9-Aminonaphth[1,2-d]imidazoles Syntheses of the bicyclic histamine analogues 4-(aminomethyl)benzimidazole (3a) and 4-aminomethyl-4,5,6,7-tetrahydrobenzimidazole (3b) and of the tricyclic analogues 9-amino-6,7,8,9-tetrahydronaphth[1,2-d]imidazole (6b) and 9-amino-4,5,5a,6,7,8,9,9a-octahydronaphth[1,2-d]-imidazole (6c) are described.

chemistry.chemical_classificationBenzimidazolechemistry.chemical_compoundchemistryBicyclic moleculeStereochemistryDrug DiscoveryPharmaceutical ScienceImidazoleHistamineTricyclicArchiv der Pharmazie
researchProduct

The triplet excited state of the biocative compound thiabendazole. Characterization and suitability as reporter for cyclodextrin complexation

2012

Fluorescence spectroscopy, laser flash photolysis (LPF), and density functional theory calculations have been performed to characterize the photobehavior of thiabendazole (1). Direct LFP of 1 results in the generation of a transient absorbing at λmax = 570 nm identified as the triplet excited state (31∗). The intersystem crossing quantum yield is 0.91, and the triplet energy is 288 kJ mol−1. The singlet–triplet energy gap is 84 kJ mol−1. The behavior of thiabendazole within CDs results in a marked enhancement of the triplet lifetime, this change is attributed to the mobility restrictions of included 1 imposed by the cyclodextrin cavities.

chemistry.chemical_classificationOptimizationCyclodextrinBeta-CyclodextrinGeneral Physics and AstronomyQuantum yieldHuman-SerumDensityProteinsPhotochemistryPolarizable continuum modelBenzimidazoleFluorescence spectroscopyIntersystem crossingQUIMICA ORGANICAchemistryExcited stateSolventTransitionFlash photolysisPolarizable continuum modelDensity functional theoryPhysical and Theoretical ChemistryApproximation
researchProduct

Synthesis of polycyclic fused benzimidazole derivatives

1977

Am easy method for the synthesis of tetraeyclie systems containing an imidazole and an iso-thiazole or an imidazole and a thiazine ring, by reacting 2H-1,3-benzothiazine-2-thion-4(3H)one with aromatic primary diarnines is reported. The structures were assigned based upon mass spectra and modes of cleavage of the compounds. The most important fragments are described.

chemistry.chemical_compoundBenzimidazoleChemistryThiazineStereochemistryOrganic ChemistryMass spectrumImidazoleJournal of Heterocyclic Chemistry
researchProduct

Herbizide, 2. Mitt. 2-Trifluormethylpyrimido[1,2-a]benzimidazole

1982

Aus der Kondensation von 2-Aminobenzimidazol (1) mit den Trifluormethyl-β-Diketonen 2a-f gehen die 2-Trifluormethylpyrimido[1,2-a]benzimidazole 3a-f hervor. Auffallende herbizide Wirksamkeit vermag 3a zu entfalten. Herbicides, II: 2-(Trifluoromethyl)pyrimido[1,2-a]benzimidazoles The condensation of 2-aminobenzimidazole (1) with the trifluoromethyl-β-diketones 2a-f furnishes the 2-(trifluoromethyl)pyrimido[1,2-a]benzimidazoles 3a-f. Marked herbicidal activity is exhibited by 3a.

chemistry.chemical_compoundBenzimidazoleTrifluoromethylChemistryDrug DiscoveryPharmaceutical ScienceOrganic chemistryMedicinal chemistryArchiv der Pharmazie
researchProduct